Haemorrhoids
Conditions
Interventions
Trial group:Probiotic preparations and probiotic products were taken. Probiotics were bifidobacteria triple live enteric capsules with main components including bifidobacteria, Lactobacillus acidophil
probiotics were inulin 50g/ time, twice a day.
Control group:Take a placebo capsule composed of vitamin C and maltodextrin powder, vitamin C capsule, orally, 2 times a day, maltodextrin powder, 50g/ time, 2 times a day
Sponsors
Shenzhen Guangming District People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patients aged 18-50 years old, grade II-IV patients, no more than 4 hemorrhoidectomy, internal hemorrhoidal ligation no more than 3.
Exclusion criteria
Exclusion criteria: 1. Severe circular hemorrhoids incarcerated, more than 4 hemorrhoidal nuclei removed; 2. History of inflammatory bowel disease; 3. Have been diagnosed with diseases that affect bowel movements, such as intractable constipation, constipated irritable bowel syndrome, and diarrheal irritable bowel syndrome; 4. Allergic to probiotic samples or ingredients; 5. Use of antibiotics or probiotics in the past 1 month; 6. Use of anti-anxiety, antidepressant or other psychotropic drugs in the past month; 7. Long-term use of constipation medications; 8. Chronic diseases of the kidney, liver, gastrointestinal tract, lungs or endocrine system; 9. Serious diseases such as type I or type II diabetes mellitus, myocardial infarction, cerebral infarction, malignant neoplasm and immunodeficiency diseases; 10. Patients who are being treated for gastrointestinal disorders that may affect intestinal function; 11. Use of foods, supplements or drugs that affect bowel function; 12. A person who is pregnant, breastfeeding or may become pregnant; 13. Persons who are illiterate, unable to understand the informed consent form or independently sign the informed consent form, or who have difficulty filling out various questionnaires; 14. Other patients who have been determined by the physician to be unsuitable for inclusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency of bowel movements (times/week);Defecation trait;Bowel pain score(Visual Analogue Scale/Score);Anal distention distress score; | — |
Secondary
| Measure | Time frame |
|---|---|
| ncidence of postoperative major bleeding; | — |
Countries
China
Contacts
Public ContactLu Ruimin
Shenzhen Guangming District People's Hospital
Outcome results
None listed